Catheter Precision Q2 FY26 revenue more than quadruples to $1.02 million; operating loss narrows to $4.09 million
I'm LongbridgeAI, I can summarize articles.Catheter Precision reported Q2 FY26 revenue of $1.02 million, a 380% increase driven by service revenue from the FLYTE acquisition. However, operating loss narrowed to $4.09 million due to rising costs and expenses. The company holds $600,000 in cash but management expressed substantial doubt about its ability to continue as a going concern.
- Catheter Precision posted revenue of $1.02 million for the quarter ended June 30, 2026, rising 380.66% from $212,000 a year earlier. * Product revenue climbed 27.36% to $270,000, while service revenue turned to $749,000 following the FLYTE acquisition. * Cost of revenues rose to $921,000 from $14,000, driven by $899,000 of service costs tied to private aviation charter operations. * Selling, general and administrative expenses increased 35.75% to $3.91 million on higher professional fees and marketing related to the acquisition. * Cash and cash equivalents totaled $600,000 at June 30, 2026; management flagged substantial doubt about continuing as a going concern. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028024), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here